Table 2

Mortality risk and risk for hospitalization in patients with CAD and IFG, IGT, or type 2 diabetes and patients with NG

Cardiac death(n = 101)§MACE(n = 385)§Death(n = 208)§Hospitalization due to ACS at 5 years(n = 269)Hospitalization due to CHF at 5 years(n = 78)
Univariate analysis
 NG1.001.001.001.001.00
 IFG1.10 (0.32–3.72)0.83 (0.48–1.45)0.78 (0.31–1.98)0.98 (0.55–1.76)0.92 (0.21–4.00)
 IGT1.48 (0.71–3.07)0.94 (0.67–1.32)1.80 (1.15–2.83)*0.90 (0.61–1.34)1.26 (0.54–2.98)
 Type 2 diabetes3.11 (1.85–5.23)*1.65 (1.31–2.08)*2.47 (1.74–3.51)*1.29 (0.98–1.69)3.13 (1.77–5.56)*
Multivariate analysis
 NG1.001.001.001.001.00
 IFG0.45 (0.06–3.42)0.81 (0.44–1.47)0.36 (0.09–1.49)0.95 (0.50–1.79)1.09 (0.24–4.83)
 IGT1.12 (0.49–2.53)0.89 (0.62–1.28)1.38 (0.85–2.24)1.01 (0.67–1.52)0.94 (0.36–2.47)
 Type 2 diabetes2.21 (1.24–3.92)*1.39 (1.07–1.81)*2.04 (1.39–2.98)*1.23 (0.90–1.68)1.72 (0.91–3.28)
  • Data are HR (95% CI).

  • *P < 0.05 vs. NG.

  • P < 0.05 vs. IFG.

  • P < 0.05 vs. IGT.

  • §Includes aborted cardiac arrests.

  • ‖Adjusted for age, sex, BMI, resting systolic and diastolic blood pressure, CCS grading for angina pectoris, SYNTAX Score, and LV ejection fraction.